Automotive Stamping Market is Anticipated to Register 5.3% CAGR through 2022-2032

With a modest CAGR of 5.3% from 2022 to 2032, the worldwide automotive stamping market is anticipated to reach a value pool of US$ 10,490.0 Million in 2022. The global market for automotive stamping is expected to reach US$ 17,581.6 million by 2032.

Stamping is a metal working process by which a desired shape and structure of a material is achieved. This metal working process is adopted in manufacturing industries engaged in processing of hardened surfaces such as sheet metal and plastics components. Stamping process forms the base of all the building process in automotive industry as more than 80 percent of the components that make up a vehicle is produced by stamping. Both the interior structural components and the exterior build components are produced by this process.

Request a report sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-1527

Since 2015, the demand for automobiles has increased exponentially after the global economic downturn during 2016. This has led to an increase in demand of the stamping machines so as to meet the demand of an impeding growth in the automotive sector. The increase in usage of stamping machines in the automotive sector attributed to the growth of stamped automotive parts and is forecast to expand at a increasing growth rates during 2022-2032.

Automotive Stamping Market Dynamics

The market for stamping machines in the automotive sector is driven by reduced lead times required for manufacturing vehicles. The machines are extremely versatile as different modules can be achieved by changing the necessary die. This process has also led to reduced labor requirements as the process can be automated with the help of computers thereby reducing the labor costs. The process helps in reducing scrap wastage as precise amount of raw material is utilized. The production cost incurred in the stamping process is very low and is replacing other metal working processes such as forging and die-casting.

Automotive Stamping: Regional Outlook

The Global automotive stamping market can be divided into seven geographical locations such as North America, Latin America, Western and Eastern Europe, Asia-Pacific region, Japan, Middle East and Africa. Asia-Pacific market is anticipated to grow steeply in the stamped components, as the automotive sector in China, Japan and India is growing at a rapid pace. In Latin America, Brazil is the strongest automotive stamped components market preceded by Mexico and Argentina, due to improved production and sales of automobiles in these regions. European countries such as U.K. and Germany are also expected to grow in the stamped component market as demand for vehicles in these regions has increased exponentially.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1527

Automotive Stamping Market: Key Players

Some of the major players which provide the Automotive Industry with Stamping Presses are

  • Schuler Group
  • AIDA Global
  • Orchid International
  • Eagle Press & Equipment Co. Ltd.
  • Hyundai Rotem
  • MacRodyne Hydraulic Presses & Automation
  • Santec Group
  • Jier North America
  • Ridgeview Industries
  • Bliss-Bret Industries

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types and applications.

Regional analysis includes:

  • North America
  • Latin America
  • Asia Pacific
  • Japan
  • Western Europe
  • Eastern  Europe
  • Middle East & Africa

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-1527

Automotive Stamping Market: Segmentation

On the basis of forming temperature, Automotive Stamping Market can be segmented as:

  • Hot Stamping
  • Cold Stamping

On the basis of Stamping process, Automotive Stamping Market can be segmented as:

  • Mechanical Process
  • Hydraulic Process
  • Pneumatic Process

On the basis of the number of stations required, Automotive Stamping Market can be segmented as:

  • Single Tool Station
  • Progressive Stations

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Pipette Tips Market is anticipated to reach a valuation of US$ 1.47 Billion by 2032 | FMI

[333 Pages Report] The pipette tips market is worth USD 680.40 million in 2022 and is expected to grow at an 8.0% CAGR from 2022 to 2032 to reach USD 1.47 billion by 2032.

Constant product innovation, rising demand for R&D, and an increasing number of healthcare settings, diagnostics, and liquid handling systems are key drivers driving pipette tips market growth as well as the pipette tips market opportunities.

Attributes Details
Pipette Tips Market CAGR (2022-2032) 8.0%
Pipette Tips Market Size (2022) USD 680.40 million
Pipette Tips Market Size (2032) USD 1.47 billion

Furthermore, there has been an increase in the number of innovations in this product category, which is fuelling demand for pipette tipsPipette tips, such as wide orifice tips, gel loading tips, standard, filtered, low-retention pipette tips, and so on, saw a significant increase in demand for pipette tips following the emergence of COVID-19 in 2020, as they were among the critical laboratory devices used to detect the virus’s presence.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15166

The filter tips product type segment of the pipette tips market in the United States is expected to grow at the fastest CAGR during the forecast period. The robotics segment had the largest pipette tips market share.

The demand for pipette tips increased dramatically as a result of the COVID-19 outbreak, as daily testing at diagnostic centres for infection detection increased influencing the pipette tips market adoption trends. However, many supply chain bottlenecks were encountered as demand for pipette tips outstripped supply.

Revenue from sales of pipette tips market increased significantly in the second half of 2020, particularly in the United States and Europe. Manufacturers of pipette tips are constructing a new plant for high-quality laboratory consumables made of functional high-tech polymers which will positively affect the pipette tips market key trends and opportunities as well as the pipette tips market future trends.

Eppendorf stated in its 2021 annual pipette tips market report that sales of pipette tips majorly its robotic pipetting systems have increased and have more than doubled since 2020. This suggests that demand for pipette tips notably robotic pipettes will rise as well along with the constructive effect on the pipette tips market future trends.

KEY TAKEAWAYS:

  • The standard product segment dominates the pipette tips market in product insight. It accounts for 32.5% of total revenue and is expected to grow at a healthy rate in the future.
  • In terms of technology insight, the non-robotic pipette tip segment is anticipated to have highest revenue in the pipette tips market share of 56.4% through 2032 and is expected to grow significantly during the forecast period.
  • In terms of application insight, the pharma and biotech segment dominates the pipette tips market, accounting for 32.3% of total revenue. The segment is expected to grow at the fastest CAGR during the forecast period, maintaining its leading position in the pipette tips market.
  • North America dominates the pipette tips market, accounting for 37.5% of the total revenue.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15166

COMPETITIVE LANDSCAPE:

New market research report on pipette tips will offer valuable insight into the market, with a focus on some of the major players such as Thermo Fisher Scientific, Sartorius AG, CORNING INC., Mettler Toledo, Tecan Trading AG, Hamilton Company, Eppendorf AG, and others.

Pipette tips market participants’ key strategic initiatives include new product development, collaborations, regional expansions, and mergers.

RECENT DEVELOPMENT:

Collaboration:

  • Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. announced a 15-year strategic collaboration agreement in 2022 to enable dedicated large-scale manufacturing in the United States of Spikevax, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline, resulting in increased use of essential lab supplies such as pipette tips.

Expansion:

  • Thermo Fisher Scientific announced a $140 million investment to expand its laboratory plastics disposables production in order to meet global demand for pipette tips during COVID-19 testing, as well as for the development and manufacturing of therapies and vaccines.

Acquisition:

  • Sartorius has acquired Biological Industries Ltd., a manufacturer of cell culture and molecular biology research products.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15166

Key Segments

By Product:

  • Standard
  • Filtered
  • Low-retention
  • Others

By Technology:

  • Robotic
  • Non-robotic

By Applications:

  • Diagnostics and Healthcare
  • Pharma and Biotech
  • Academia and Education
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Automotive Air Filter Market Projected to Reach US$ 6,680 million by 2032 | FMI

The market for automotive air filters is predicted to be worth US$ 5,321.3 million in 2022 and US$ 6,680 million by 2032. During the forecast period of 2022–2032, the market is anticipated to grow at a CAGR of 2.3%.

An automotive air filter is a device that is made up of fibrous materials that removes solid particulates like pollen, dust, bacteria, and mould from the intake air. A chemical type of air filter consist of a catalyst or absorbent for removing molecular contaminants like ozone or volatile organic compounds. Air filters are being used in applications where air quality is of vital importance, notably in building ventilation systems and in vehicle engines.

Download Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1684

The cabin automotive air filter is a paper-pleaded filter, which is located in the air intake from outside for the passenger compartment of the vehicle. Some of the automotive air filters are rectangular or similar in shape as that of the combustion air filter, others have a unique shape to fit the available space of outside-air intakes.

The very first automaker to provide a disposable air filter in order to clean the ventilation system was Nash Motors. The combustion automotive air filter restricts particulate matter to enter into the engine’s cylinders, where it can cause oil contamination and mechanical wear.

Nowadays, fuel injected vehicles are using a paper pleated filter element that is in a flat panel form. These filters are placed in a plastic box connected with a throttle body. Older vehicles using throttle body or carburettors fuel injection system use a cylinder air filter, which are a few inches and are between 6 to 16 inches.

Global Automotive Air Filter Market: Drivers and Restrains

The ever increasing automobile market, and particularly the cars market is the major driving factor for the growth of global automotive air filter market and specifically the cabin filter market due to the cars market. Also automobile consumers are becoming aware about the importance of air filter for purified air and staying isolated in their passenger cabin from the atmosphere dirt that leads to the booming cabin air filter aftermarket.

Request for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-1684

However, the flourishing electric vehicle market is restricting the growth of intake air filter, which is specifically required in the internal combustion engines intake manifold. Thus it can slowdown the growth of global automotive air filter market.

Global Automotive Air Filter Market: Region Wise Outlook

The global automotive air filter market can be divided into seven regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa. Europe is the dominant region in the global automotive air filter market owing to the ever increasing automobile market in this region. Asia Pacific is the second major contributor in the automotive air filter market due to the automobile giants such as Maruti, Hero and other companies.

The companies such as General Motors, Ford are having a significant contribution in the global automobile market making North America a considerable player in the global automotive air filter market. Japan is technologically advanced country in terms of automotive markets and so the technology of automotive air filter is very common in this country. Latin America and Middle East and Africa are at a nascent stage in the automotive air filter market but is anticipated to have a modest CAGR in the forecasted period.

Ask the Analyst: https://www.futuremarketinsights.com/askus/rep-gb-1684

Global Automotive Air Filter Market: Key Players

Some of the key players in the global automotive air filter market are as follows:

  • MANN+HUMMEL
  • Donaldson Company, Inc
  • NGK INSULATORS, LTD
  • Sogefi SpA
  • Mahle International GmbH
  • C & R Fab Media Private Limited
  • Melkev Machinery Impex
  • Global Filters
  • Simplex Corporation

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, technology and applications.

Global Automotive Air Filter Market: Segmentation

On the basis of type, the automotive air filter market can be segmented as:

  • Cabin air filter
  • Intake air filter

On the basis of filtering media, the automotive air filter market can be segmented as:

  • Synthetic
  • Cellulose
  • Activated carbon
  • Particle

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Formulation Development Outsourcing Market securing a valuation of US$ 33.23 Bn by 2032 | FMI

The formulation development outsourcing market is predicted to account for US$ 66.6 billion in 2032, up from US$ 31 billion in 2021, advancing at a CAGR of 7.2% during the forecast period (2022-2032).

The increased R&D costs are expected to increase demand for formulation development outsourcing. Formulation development outsourcing services are widely used by small and medium-sized pharmaceutical companies that lack the necessary resources.

The majority of pharmaceutical companies use it to reduce the amount of time spent on outsourcing services for formulation development as a result of trial-related costs. The expansion of the formulation development outsourcing business is responsible for the pharmaceutical industry’s increasing reliance on partnerships with academic institutions.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15131

The market value of formulation development outsourcing can be significantly harmed by increases in the cost and demand for various medications and raw materials. The medical medication patent protection expiration was a marketing strategy developed by the formulation development outsourcing business to encourage market growth.

The formulation development outsourcing market size has increased as a result of the rise in the number of biopharmaceutical and pharmaceutical companies that contract out their work. In North America, the market for formulation development outsourcing held a substantial share of 26.8% in 2021.

As an illustration, many clinical trials are conducted in the United States. Furthermore, it is anticipated that Europe will hold the formulation development outsourcing market share. The government’s supportive initiatives, sedentary lifestyles, and the rise in chronic illnesses are driving the market in this region.

Key Takeaways 

  • The formulation development outsourcing market is predicted to develop at a CAGR of 7.2%, with a market share of US$ 66.6 billion through 2032.
  • The formulation development outsourcing market in North America holds a sizable share of 22.8 in 2021.
  • The formulation development outsourcing market in Asia Pacific is anticipated to have a significant CAGR of 8.1% through 2032.
  • The formulation development outsourcing market had a share of US$ 31 billion in 2021.
  • The oral segment of the formulation development outsourcing market, based on formulation, had a revenue share of 63.6% in 2021.
  • The formulation development segment of the formulation development outsourcing market, based on services, had a revenue share of 76.6% in 2021.

PDF Broacher @ https://www.futuremarketinsights.com/askus/rep-gb-15131

Competitive Landscape:

Some of the primary measures players are employing to take advantage of the formulation development outsourcing market opportunities include frequent product launches, geographic expansions, and distribution agreements to expand their consumer base.

Key Players

  • SGS S.A.
  • Intertek Group plc
  • Recipharm
  • Lonza
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Element
  • Labcorp
  • Thermo Fisher Scientific, Inc. (Patheon)
  • Catalent Inc.

Recent Developments:

  • In 2019, Intertek enlarged its Melbourne-based laboratory for pharmaceutical services.
  • In 2021, Cataleny Inc. announced that it had acquired the packaging and manufacturing divisions of Acorda Therapeutics Inc.
  • In 2021, Quotient BioSciences also disclosed plans to acquire Arcinova, a UK-based business. With this acquisition, Quotient Bioscience is able to offer more services, such as medicinal goods, clinical testing, and drug substance development.
  • 2020 saw the announcement by Catalent Inc. of the acquisition of MaStherCell Global Inc. The biotech sector is strengthening its position as a result of this increase, and new methods for gene therapies are made available.

Key Segments

By Service:

  • Preformulation
  • Formulation Development

By Formulation:

  • Oral
  • Injectable

By Therapeutic Area:

  • Oncology
  • Infectious Diseases
  • Neurology
  • Hematology
  • Respiratory
  • Cardiovascular
  • Dermatology
  • Others

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15131

Table of Content
1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

Click Here for Full Toc

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Virology Market to reach a valuation of US$ 3.53 Bn by 2032 | FMI

[250 Pages Report] Virology, the study of viruses, is an unparalleled branch of life sciences. With immensely high prevalence of diseases such as flu, hepatitis, AIDS, and STDs, the importance of virology is repeatedly highlighted. The global virology market is expected to grow over 2022-2032.

FMI’s research identifies growing infectious diseases as a key force driving the market throughout the forecast period.

Key Drivers: Virology Market

Early in 2016, the WHO officially issued a warning about the possible spread of zika virus to each Western Hemispheric region, as the disease vector Aedes aegypti was found to thrive strong in tropical and sub-tropical climatic conditions. This has been a key driver of market growth throughout 2016.

The virology market is constantly catering to the prevention and cure needs put forth by the healthcare sector; however, several diseases continue to demand R&D of novel applications, driving the growth of virology market. Various treatments and diagnostic processes also employ virology applications, further fuelling the market growth.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1150

Burgeoning applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology is another factor fostering the overall growth of the virology market.

Moreover, the field of virology is extending in various forms, including molecular virology, paediatric virology, computational virology, and many more, prompting at increasing research findings throughout the forecast period. Research prospects are high and FMI indicates a continuing need for trained virologists in the near future.

Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market.

Key Restraints to Market Growth

Maintaining the quality and safety standards of viral a controlling therapy has been a longstanding challenge, which is anticipated to hamper the market in the forecast period as well. Moreover, stringent approval processes for antiviral drugs is also foreseen to be a restraint to market growth. Another factor identified for affecting the market growth includes resistance toward and side effects of antiviral drugs for new treatment options.

Current Trends in the Virology Field

In 2015, the virology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses. In 2016, zika virus is dominating the research, with better prospects in the near future. Virologists are persistently investigating novel applications for viruses. Currently, an ongoing research is experimenting on the exploitation of viruses for plant production, aiming at the efficient production of high quality, eco-friendly food.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1150

Global Virology Market: Competitive Landscape

By 2017 end, a few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. Following expiry of these blockbuster drugs, the market is estimated to discover a dynamic competitive landscape. The generic competition in the virology market will be at a high pace 2017 onward.

Apart from expiring drugs, the market also has some late stage pipeline drugs, including Inavir, Elvitegravir, Vicriviroc, Rilpivirine, and Rapiacta. These drugs are set to enter the global market, fostering the competition globally.

Regional Outlook: Global Virology Market

North America is the largest virology market led by the U.S., owing to technological advancements such as rapid, portable diagnostics. N. America is expected to retain the top market position over the forecast period as well.

Europe is projected to maintain the position as the second largest market globally. During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for viral diseases.

Japan is currently a growing virology market, which is estimated to grow at a remarkable CAGR through to 2025. However, APEJ and Africa are expected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable revenue share to the APEJ virology market.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1150

Key Players in the Global Virology Market

The notable players identified in the global virology market include GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.

Merck and Co. Inc. has several drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzeimer’s, ebola, and HIV. The company also has many other candidates, which are currently under review.

Abivax, a high profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikungunya viruses. The company has a few more candidates against HIV and ebola, currently under development.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Virology Market: Segmentation

Based on product type, the global virology market is segmented into

  • Diagnosing Test
  • DNA Viruses
  • RNA Viruses
  • Prions Diagnostic Test
  • Other Viral Tests
  • Viral Infection Controlling Methods
  • Immunoprophylaxis
  • Active Prophylaxis (Vaccines)
  • Passive Prophylaxis
  • Antiviral Chemotherapy
  • Virucidal Agents
  • Antiviral Agents
  • Immunomodulators
  • Interferons
  • Cytokines

FMI’s research on the global virology market provides a 10-year forecast, segmenting the market on the basis of application, end-use, and region.

Based on application, the global virology market is segmented into

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Urinary Tract Infections
  • Eye Infections
  • CNS Infections
  • Sexually Transmitted Diseases
  • Perinatal Infections

According to the end-user, the market is segmented into

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centres
  • Blood Banks
  • Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Healthcare Biometrics Market is likely to boost up to US$ 3.4 Bn in 2022

[309 Pages Report] Healthcare Biometrics Market to Reach US$ 17.9 Billion by 2032, owing to the Increasing number of Healthcare Fraud; Healthcare Biometrics Market to Record an 18.1% CAGR through 2032. The demand for healthcare biometrics is likely to rise as the number of healthcare frauds is rising all around the globe and the advancement of new technology brings the security awareness related to the data stolen, inventory loss, and other frauds.

The healthcare biometrics market size is likely to rise due to the number of end-user’s industries adopting the healthcare biometrics devices, including hospitals, clinics, healthcare institutions, research, clinic laboratories, etc.

The US market is estimated to dominate the healthcare biometrics market share due to increasing fraud and developing healthcare infrastructure, which is likely to increase the adoption of healthcare biometrics.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14886

The healthcare biometrics applications are monitoring various scans on the patient, including fingerprint, thumbprint, palm print, face, and others. In which the fingerprint is one of the common prints used in the documentation, identification of data, and other legal activities.

These factors are supposed to rise the healthcare biometrics market opportunities in the forecast period from 2022 to 2032 all around the regions.
The sales of healthcare biometrics are likely to rise on the international market in developing countries to secure the patient’s health and data. The manufacturing companies are playing a key contributing role in the healthcare biometric market growth.

The healthcare institution segment is anticipated to dominate the healthcare biometrics market growth with a CAGR of 17.2% during the forecast period from 2022 to 2032. The number of healthcare is provided by the healthcare institution, which supposes to enlarge the adoption of healthcare biometrics in the coming year.

 Key Takeaways:

  1. Based on technology, the multi-factor authentication segment is likely to dominate the healthcare biometrics market share with a CAGR of 5.8% during the forecast period 2022 to 2032.
  2. Based on end users, healthcare institutions are anticipated to lead the healthcare biometrics market size in the forecast period 2022 to 2032.
  3. The US holds a prominent role in the healthcare biometrics market trends due to the well-establish healthcare infrastructure in the country.
  4. By 2032, the healthcare biometrics market share is anticipated to rise to the valuation of US$ 17.9 Billion with a CAGR of 18.1%.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14886

Competitive Landscape:
Several key competitors are generating huge revenue as per the healthcare biometrics market survey by taking on various methods such as collaborating, partnership merges and others. The key driving companies are using all these things to carry out maximum growth in the healthcare biometrics market future trends.

Some of the key companies are as follows:
These are NEC Corporation, Fujitsu Limited, 3M Cogent, Inc., Morpho, Imprivata, Inc., Suprema Inc., and others. All these leading companies are looking to expand the healthcare biometrics market in the forecast period from 2022 to 2032.

Segments:

By Technology:

  • Single-factor Authentication
  • Multi-factor Authentication
  • Signature Recognition
  • Voice Recognition
  • Other Behavioral Recognition
  • Multi-factor Recognition
  • Biometrics with PIN
  • Two-factor Biometrics
  • Three-factor Biometrics

By Application:

  • Patient Identification & Tracking
  • Medical Record Security & Data Center Security
  • Care Provider Authentication
  • Home/Remote Patient Monitoring
  • Pharmacy Dispensing
  • Others

Get Customization on this Report for Specific Country@ https://www.futuremarketinsights.com/customization-available/rep-gb-14886

By End User:

  • Hospitals & Clinics
  • Healthcare Institutions
  • Research & Clinical Laboratories
  • Respiratory Distress Syndrome

By Region:

  • North America
  • Asia Pacific
  • Europe
  • Middle East & Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedInTwitterBlogs

Breast Lesion Localization Market is likely to reach US$ 382 Million by 2032 | FMI

[309 Pages Report] As per the study at FMI, the breast lesion localization market is valued at US$ 256 million in 2022 and is expected to reach US$ 382 million by 2032, growing at a 4.1% CAGR through 2032.

Rising cases of breast cancer led by increased government spending on the research and development of drugs and services to counter the disease are flourishing in the breast lesbian localization market, enhancing the healthcare structure while spreading awareness about early diagnosis.

Growing chronic diseases like breast cancer and multiple diagnosis methods, including early detection and screening, coupled with it being the most prevalent cancer, are helping the breast lesion localization market gain traction.

Breast cancer’s early detection and screening, and treatment, according to that diagnosis, have gained a good amount of traction in the breast lesion localization market. Breast cancer is the second leading cancer-related death in women worldwide.

The use of cutting-edge technology like artificial intelligence, integrated healthcare platforms, and digital monitors has helped the healthcare and diagnosis sector to evolve and get set up in new regions.

Request for Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14845

Government programs also promote multiple kinds of diagnosis, treatment, and screening processes that lastly help doctors and patients understand the real-time situation, pushing the demand for breast lesion localization.

High-cost range of these systems, newer, cheaper system alternatives, lower awareness, and incompetent health workers that need to be trained and upskilled are the major restraints for the Breast lesion localization market.

Uncertain FDA approvals, such as nuclear regulatory clearance, along with a shortage of skilled oncologists, are restricting the growth of breast lesion localization.

KEY TAKEAWAYS:

  • United States thrives at a CAGR of 3.9% between 2022-2032 and is expected to hold a market revenue of US$ 136 Mn by the end of 2032.
  • Increasing breast cancer cases coupled with advanced diagnosis options while upgrading the healthcare system and their integration with latest technology like AI and IOT are fueling the growth in this region.
  • Breast Biopsy segment is the largest segment by the usage type and will hold the biggest portion of the market in the forecast period, thriving at CAGR of 3.5% through 2032. The growth of segments is attributed to easy removal and short time span and lower post-surgery impacts than the lumpectomy.
  • The UK, being the highest growing market globally, will hold US$ 18.2 Mn by the end of 2032 as it thrives on a promising CAGR of 4.4% between 2022-2032

Request for Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14845

COMPETITIVE LANDSCAPE:

Some of the breast lesion localization market competitors listed in the FMI’s study on Breast lesion localization market are Hologic Inc, Becton, Dickinson and Company, Merit Medical System, Leica Biosystems, Nussloch GmbH and Argon Medical Devices.

Recent Developments

  • Hologic Inc has introduced LOCalizer, the wire-free breast lesion system that is designed to mark and guide non-palpable breast lesions using a miniature. This innovative technology pushes the market and increases the demand for breast lesion localization processes.
  • CMerit Oncology has upgraded its scout radar localization that helps in reducing the OR delays and targets the affected tissue and points it out, easing the surgery processes.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

4. Market Background and Foundation Data Points

Toc Continued…

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedInTwitterBlogs

Medical Chairs Market to reach a valuation of US$ 13.7 Billion by 2032 | FMI

Growth in the medical chairs market is increasing in with rising prevalence of physical ailments combined with advancements in control systems. Mobility challenges have long been a source of concern among the elderly, and integrated robotics has prompted a surge in a study into their applications in home-based settings.

As a result, rapid technologically advancements in wheelchairs to be commercialized in developing countries will drive the growth. Electric wheelchairs are extensively utilized in airports, hospitals, theatres, tourist attractions, and other public places.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14811

The medical chairs market is predicted to expand with growing need of treatment or inspection worldwide. Furthermore, an increase in the geriatric population for rehabilitation purposes is aiding the market growth.

Increased prevalence of chronic diseases, as well as technological developments in the operation and design of medical chairs, are all contributing to the market’s growth. Road accidents, spinal cord injuries, meningitis, and job injuries are all contributing to the medical chairs market’s rise.

Smart wheelchairs are gaining immense traction as they are a blend of state of the art robotics and advanced electronics. Many elderlies who lead a solitary lifestyle prefer the use of these power wheelchairs and their quality of life, in general, has improved. Owing to these trends, the market is anticipated to register a CAGR of 6.0% from 2022 to 2032.

Specialty medical chairs are pieces of medical equipment that aid patients in gaining more flexibility or convenience as a result of various surgical operations. These chairs are designed to provide comfort to patients during treatment and to aid healthcare professionals and physicians in completing the procedure or any other treatment.

The development of the medical chairs market is reliant on the increasing popularity of powered wheelchairs, the rise in the adoption of automotive vehicles and the increase in the prevalence of temporary or permanent mobility issues.

Key Takeaways from Market Study

· Dental chairs hold over 20.0% market value share in 2021 and are expected to display a CAGR growth of 6.0% over the forecast period.

· Based on technology, the hydraulic medical chairs segment accounted for a demand share of over 40.7% in 2021. Hydraulic chairs have simpler, easy to use controls, and are known for their fluid movement and adaptability to broad weight.

· Hospitals held a higher share in the medical chairs market by a value of 21.1% in 2021.

· North America medical chairs market is slated to hold a value share of 36.0% at the end of the forecast period owing to the growing geriatric population and rising cases of paralysis and spinal injuries in the region.

“With rise in capitalization on the adoption of power medical chairs for mobility assistance, the medical chairs market is expected to witness robust growth over the forecast period,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14811

Market Competition

Recognition, acquisitions, expansion, development of an extensive product and product launches are the key strategies adopted by manufacturers and integrators to increase the consumer base in different geographies.

· In October 2021, Invacare Corporation announced a sponsorship agreement with Rob Mendez (football coach), a user of Invacare® Storm Series® Torque™ power wheelchair.

· In January 2019, Midmark Corp. announced the launch of two new bariatric side chairs for extended patient comfort.

What does the report cover?

Future Market Insights offers a unique perspective and actionable insights on the medical chairs market in its latest study, presenting a demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research is based on products- (patient chairs [reclining patient chairs, manual patient chairs, and convertible patient chairs], x-ray chairs, ophthalmology chairs, dental chairs, surgical chairs, exercise and activity chairs, and paediatric chairs), by technology- (powered medical chair, manual chair, and hydraulic medical chair), and by end-user (hospitals, ambulatory surgical centres, outpatients facilities, speciality clinics, long term care centres, skilled nursing facilities, cancer research institute, and others), across seven key regions of the world.

Key Market Segments Covered in Medical Chairs Industry Research

Product:

  • Patient Chairs
    • Reclining Patient Chairs
    • Manual Patient Chairs
    • Convertible Patient Chairs
  • X-ray Chairs
  • Ophthalmology Chairs
  • Dental Chairs
  • Surgical Chairs
  • Exercise and Activity Chairs
  • Paediatric Chairs

Technology Type:

  • Powered Medical Chair
  • Manual Chair
  • Hydraulic Medical Chair

End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Outpatient Facilities
  • Specialty Clinics
  • Long Term Care Centres
  • Skilled Nursing Facilities
  • Cancer Research Institutes
  • Others

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedInTwitterBlogs

Breast Imaging Market is anticipated USD 4.3 billion in 2022 to USD 8.5 billion by 2032

[343 Pages Report] The breast imaging market is expected to increase at a 7.1% CAGR from an anticipated USD 4.3 billion in 2022 to USD 8.5 billion by 2032.

Technological improvements, the rising prevalence of breast cancer, the increasing number of screening programs, and the increasing number of conferences and symposiums concentrating on spreading awareness about the advantages of early screening and diagnosis are all driving breast imaging market growth along with breast imaging market adoption trends.

Attributes Details
Breast Imaging Market CAGR (2022-2032) 7.1%
Breast Imaging Market Size (2022) US$ 4.3 Billion
Breast Imaging Market Size (2032) US$8.5 Billion

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14796

The rising breast imaging markets, increasing government and private investments to support the increasing demand for breast imaging, and a better reimbursement picture is likely to provide breast imaging market participants with a wide variety of breast imaging market key trends and opportunities prospects.

The National Cancer Institute conducts and encourages the development of recommendations for different organisations. Breast cancer is one of the most common causes of mortality among women.

As mammography is the standard procedure for screening breast cancer, governments and other healthcare organisations all over the world are taking steps to ensure that women have access to mammography screening. The global demand for breast imaging and mammography is expanding as a result.

There have been a lot of developments in the area that reduce over-diagnosis and improve sensitivity to identify tiny carcinomas. These ongoing improvements in this discipline are projected to boost the global breast imaging market‘s mammography segment.

The development and increased usage of improved mammography machines with novel technology are fueling breast imaging market future trends.

The Asia Pacific area is a prominent revenue generator in the breast imaging market. The rising prevalence of breast cancer, rising healthcare expenditure, an increase in the number of breast cancer awareness programs, and high government spending on breast cancer research studies in several Asia Pacific countries are the major factors driving the Asia Pacific breast imaging market opportunities.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14796

KEY TAKEAWAYS:

  • In the United States, the breast imaging market is estimated to reach US$ 3.1 Billion by 2032, increasing at a CAGR of 6.9% through 2032.
  • The breast imaging market in the United Kingdom is expected to be worth US$ 350.3 Million by 2032, with a CAGR of 5.9% through 2032.
  • China’s breast imaging market is expected to reach US$ 613.6 Million by 2032, with a CAGR of 6.4% through 2032.
  • The market for breast imaging in Japan is expected to be valued at US$ 494.9 Million by 2032, expanding at a 5.4% annual rate through 2032.
  • South Korea is expected to reach a market size of US$ 308.8 Million in breast imaging by 2032, with a CAGR of 5.0% through 2032.
  • The breast imaging market’s ionizing breast imaging segment from the technology category is predicted to develop at a CAGR of 7.0% through 2032.
  • By 2032, the hospitals & clinics sector in the breast imaging market’s end-user category will grow at a CAGR of 7.0%.

COMPETITIVE LANDSCAPE:

New market research report on Breast Imaging says that Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, and Carestream Health., are among the legacy players vendors.

The research offers a comprehensive competition analysis of these top competitors in the breast imaging market, including breast imaging market growth, breast imaging market share, breast imaging market adoption trends and important market strategies.

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14796

Recent Development in the Breast Imaging:

  • Densitas Inc. announced collaboration with Mammography Educators, LLC in November 2020 to build an artificial intelligence-powered telehealth technologist training platform that would promote business continuity in mammography clinics.
  • Hologic, Inc. announced the commercial availability of 3DQuorum Imaging Technology powered by Genius AI in Europe in October 2020. According to the company’s disclosures, the 3DQuorum Imaging Technology uses Genius AI-powered analytics to reconstruct high-resolution 3D data. This technology aids in lowering picture interpretation time.

Key Segments

By Technology:

  • Ionizing Breast Imaging
    • Mammography
    • Positron Emission Tomography-Computed Tomography (PET-CT)
    • Molecular Breast Imaging (MBI)
    • Positron Emission Mammography (PEM)
    • Cone-beam Computed Tomography (CBCT)
  • Non-ionizing Breast Imaging
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-breast Ultrasound (AWBU)
    • Breast thermography
    • Electric Impedance Tomography
    • Optical Imaging

Explore Other Reports Links From Healthcare Market

Molecular Breast Imaging Market

Optical Imaging Market

Automated Breast Ultrasound Systems Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedInTwitterBlogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Magnetic Resonance Imaging (MRI) Contrast Agents Market worth US$ 1.23 Bn by 2029

The global Magnetic Resonance Imaging (MRI) Contrast Agents Market recorded sales worth U.S. $ 871.0 Mn in the year 2021. The market is expected to grow 1.3X over the forecast period 2022-2029. The industry will record sales worth U.S. $ 1.23 Bn by the end of 2029.

The Magnetic Resonance Imaging (MRI) Contrast Agents Market is expected to grow rapidly in the foreseeable future, due to surging demand for image-guided surgical procedures. Advancements in diagnostic imaging and growing number of diagnostic centers offering magnetic resonance imaging (MRI) services create a significant opportunity for players operating in the MRI contrast agents market.

Download Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-11023

Increasing investments in the magnetic resonance imaging contrast agents market by key market players and new product launches are major factors expected to boost growth further. The global magnetic resonance imaging contrast agents market was valued at US$ 765 Mn in 2021, and is expected to exhibit a CAGR of 4.4% during the forecast period (2022–2029).

Key Takeaways of MRI Contrast Agents Market Study

  • Extracellular fluid (ECF) agents contributed more than three-fourth value share of the magnetic resonance imaging contrast agents market in 2021. This can be attributed to the availability of more patient-compliant products, and better clinical outcomes due to their brief vascular phase, rapid distribution in the extracellular space, and faster elimination through renal systems than other contrast agents.
  • Hospitals represented the highest market value share, followed by diagnostic centers, due to higher installed base of MRI units in hospitals and substantial visit to outpatient departments for the treatment and diagnosis of several disorders.
  • North America holds the highest revenue share in the global magnetic resonance imaging contrast agents market, owing to significant number of MRI scans performed with contrast agents.
  • Government initiatives towards the development of modern healthcare centers and financial support towards the growth of medical imaging technologies in Asian countries are expected to drive the growth of the magnetic resonance imaging contrast agents market in the region.

Request for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-11023

New Product Launches – Imperative Strategy for Market Players

Increasing introduction of new MRI contrast agents is the major factor responsible for intense competition among market players. Several companies are focusing on launching new magnetic resonance imaging contrast agents to increase their product sales and expand market share. For example, in March 2017, GE Healthcare launched Clariscan (gadoteric acid), a new macrocyclic MRI contrast agent, in Europe, and in July 2021 in South Korea.

Magnetic Resonance Imaging (MRI) Contrast Agents Market, By Category

By Product Type:

  • Paramagnetic Contrast Agents
    • Extracellular Fluid (ECF) Agents
    • Organ-Specific Agents
    • Blood Pool Contrast Agents (BPCAs)
  • Supermagnetic Contrast Agent

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Ask the Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-11023

What else is in the report?

Future market insights offers a unique perspective and actionable insights on the magnetic resonance imaging contrast agents market in its latest study, presenting historical demand assessment from 2014–2021 and projections for 2022–2029, based on product type (paramagnetic contrast agents and superparamagnetic contrast agents) and end user (hospitals, ambulatory surgical centers, and diagnostic centers) across seven key regions.

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

https://medium.com/@vishal.tupkar/the-global-wearable-medical-devices-market-size-is-expected-to-reach-a-market-valuation-of-us-27-29-adabd97e11b7

https://www.evernote.com/shard/s703/client/snv?noteGuid=0677fcb7-09c8-07e7-bced-67de7afb9a87&noteKey=d4edafdc24758ae6a83cacf4aa9b9de2&sn=https%3A%2F%2Fwww.evernote.com%2Fshard%2Fs703%2Fsh%2F0677fcb7-09c8-07e7-bced-67de7afb9a87%2Fd4edafdc24758ae6a83cacf4aa9b9de2&title=Wearable%2BMedical%2BDevices%2BMarket%2BKey%2BPlayers%252C%2BSWOT%2BAnalysis%252C%2BKey%2BIndicators%2B%2526%2BForecast%2BBy%2B2032

https://www.tumblr.com/researchvishal/702249331398410240/wearable-medical-devices-market-research

https://www.xing.com/discover/detail-activities/6722216853.8a5721

https://london-news-community.tribeplatform.com/general/post/wearable-medical-devices-market-global-analysis-size-share-growth-uKUbyOw2eQahAXP

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs